Madagascar vs Tunisia: Antiretroviral therapy coverage for PMTCT
Madagascar
30.0%
in 2024
Tunisia
32.0%
in 2024
Madagascar rank
77th
Tunisia rank
75th
Antiretroviral therapy coverage for PMTCT over time
- Madagascar
- Tunisia
How they compare
Tunisia currently reports 32.0% against 30.0% in Madagascar, a difference of 2.0%.
That makes Tunisia's figure about 1.1 times Madagascar's.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Madagascar ranks 77th and Tunisia ranks 75th of 84 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Madagascar | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 1.7% | 0.6% | Tunisia |
| 2010s | 7.8% | 15.5% | 7.7% | Tunisia |
| 2020s | 21.4% | 34.4% | 13.0% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Madagascar or Tunisia?
- Tunisia, at 32.0% against 30.0% in Madagascar as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Madagascar and Tunisia?
- 2.0%, with Tunisia ahead.
- How many years of comparable data are there for Madagascar and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Madagascar and Tunisia rank globally for antiretroviral therapy coverage for pmtct?
- Madagascar ranks 77th and Tunisia ranks 75th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).